CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		44,618,357
Beginning balance at Dec. 31, 2021	$ 635,180	$ 4	$ 777,074	$ (1,382)	$ (140,516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued upon exercise of options (in shares)		7,765
Common stock issued upon exercise of options	70		70
Issuance of common stock for vesting of restricted stock units (in shares)		278,002
Shares repurchased for withholding tax on restricted stock units (in shares)		(81,357)
Shares repurchased for withholding tax on stock awards	(1,589)		(1,589)
Issuance of common stock under cashless warrant exercise (in shares)		99
Stock-based compensation expense	2,908		2,908
Net loss	(23,296)				(23,296)
Foreign currency translation gain	2,184			2,184
Ending balance (in shares) at Mar. 31, 2022		44,822,866
Ending balance at Mar. 31, 2022	$ 615,457	$ 4	778,463	802	(163,812)
Beginning balance (in shares) at Dec. 31, 2022	45,197,249	45,197,249
Beginning balance at Dec. 31, 2022	$ 349,881	$ 5	783,042	(7,235)	(425,931)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for vesting of restricted stock units (in shares)		237,333
Issuance of common stock for vesting of stock awards	0
Shares repurchased for withholding tax on restricted stock units (in shares)		(72,306)
Shares repurchased for withholding tax on stock awards	(123)		(123)
Stock-based compensation expense	1,182		1,182
Net loss	(16,849)				(16,849)
Foreign currency translation gain	$ 112			112
Ending balance (in shares) at Mar. 31, 2023	45,362,276	45,362,276
Ending balance at Mar. 31, 2023	$ 334,203	$ 5	$ 784,101	$ (7,123)	$ (442,780)